Cyfra 21-1 ein neuer tumormarker aus der cytokeratinreihe in der differential-diagnostik von lungenerkrankungen
Oremek GM, Seiffert UB, Siekmeier R and Kirsten R: Cyfra 21-1 ein neuer Tumormarker aus der Cytokeratinreihe in der Differential-diagnostik von Lungenerkrankungen. Med Klein 90: 23-26, 1995.
Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors
Yamaguchi K, Abe K, Kamoya T, Adachi I, Taguchi S, Otsubo K and Yanaihara N: Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 43(8): 3932-3939, 1983.
Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma
Maruno K, Yamaguchi K. Abe K, Suzuki M, Saijo N, Moshima Y, Yanaihara N and Shimosato Y: Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 49: 629-632, 1989.